Finance

Lists
Why is 300255 down 2,02%?
Dive Deeper
300255:SHE
Hebei Changshan Biochemical Pharm Co Ltd
19,88 CN¥
-2,02%
(-0,41) 1D
16 հոկ, 15:04:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300255...
Open
20,65 CN¥
High
21,15 CN¥
Low
19,75 CN¥
Mkt. cap
18,27 մլրդ
Avg. vol.
17,59 մլն
Volume
21,03 մլն
52-wk high
71,71 CN¥
52-wk low
19,75 CN¥
EPS
-0,38 CN¥
Shares outstanding
919,06 մլն
No. of employees
1 հզր
Open
20,65 CN¥
High
21,15 CN¥
Low
19,75 CN¥
Mkt. cap
18,27 մլրդ
Avg. vol.
17,59 մլն
Volume
21,03 մլն
52-wk high
71,71 CN¥
52-wk low
19,75 CN¥
EPS
-0,38 CN¥
Shares outstanding
919,06 մլն
No. of employees
1 հզր
News stories
From web sources and news partners
About Hebei Changshan Biochemical Pharm Co Ltd
CEO-
Employees1,19 հզր
Founded1992
Headquarters-
Sector-
Websitehbcsbio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
189,61 մլն
193,91 մլն
256,10 մլն
219,72 մլն
Cost of goods sold
164,51 մլն
281,46 մլն
193,11 մլն
179,86 մլն
Cost of revenue
164,51 մլն
281,46 մլն
193,11 մլն
179,86 մլն
Research and development expenses
8,72 մլն
9,51 մլն
7,23 մլն
8,69 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29,72 մլն
91,72 մլն
30,76 մլն
30,39 մլն
Operating expense
33,60 մլն
143,40 մլն
38,30 մլն
42,40 մլն
Total operating expenses
198,11 մլն
424,86 մլն
231,40 մլն
222,26 մլն
Operating income
-8,50 մլն
-230,95 մլն
24,70 մլն
-2,54 մլն
Other non operating income
-1,50 մլն
-28,67 մլն
-3,36 մլն
3,51 մլն
EBT including unusual items
-21,20 մլն
-301,55 մլն
5,20 մլն
-24,37 մլն
EBT excluding unusual items
-34,61 մլն
-282,26 մլն
-355,86 հզր
-25,59 մլն
Income tax expense
-435,25 հզր
8,93 մլն
1,82 մլն
761,85 հզր
Effective tax rate
2,05%
-2,96%
35,03%
-3,13%
Other operating expenses
-723,45 հզր
5,43 մլն
2,02 մլն
759,88 հզր
Net income
-15,73 մլն
-313,08 մլն
5,87 մլն
-22,63 մլն
Net profit margin
-8,29%
-161,45%
2,29%
-10,30%
Earnings per share
-
-
-
-
Interest and investment income
2,00 մլն
531,86 հզր
117,28 հզր
28,28 հզր
Interest expense
-19,57 մլն
-28,42 մլն
-21,82 մլն
-23,56 մլն
Net interest expenses
-17,56 մլն
-27,89 մլն
-21,70 մլն
-23,53 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
9,49 մլն
-214,14 մլն
41,52 մլն
14,11 մլն
Gain or loss from assets sale
17,64 հզր
228,40 հզր
-
6,30 հզր
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps